This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.

 

This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?
ESC-HF
Prague
2023
Symposium

Date and time:

20.05.23 at 15:00-15:45 CEST

Type:

Congress:
Speakers:

Welcome video

ATTR cardiomyopathy: From pathophysiology to prognosis

Diagnosing ATTR cardiomyopathy in clinical practice

Disease management: Where are we now and where are we going?

Q&A

Summary

properties.alt

Marianna Fontana

Royal Free Hospital, London, UK


Marianna Fontana, M.D., Ph.D., FRCP, is Professor of Cardiology and is an Honorary Consultant Cardiologist at the Royal Free Hospital, University College London, where she is Director of the UCL Cardiac MRI unit, deputy Head of Centre for Amyloidosis and deputy clinical lead of the National Amyloidosis Centre.

 

Prof. Fontana obtained her M.D. and qualifications as a cardiologist at the University of Pisa in 2011. In 2012 she obtained a BHF Clinical Research Training Fellowship to undertake a Ph.D. at UCL which focused on CMR in cardiac amyloidosis. In 2015 she became Senior Lecturer at UCL, Honorary Consultant Cardiologist and Director of the UCL CMR unit at the Royal Free Hospital, which she founded. In 2018 she was awarded an Intermediate Clinical Fellowship by the BHF. She was appointed deputy Head of Centre for Amyloidosis and Acute Phase Proteins and deputy clinical lead of the National Amyloidosis Centre in 2019. She took up the chair of Cardiology at UCL in 2020.

 

Prof. Fontana’s major clinical and research interests are in the delivery of efficient and effective care for patients with amyloidosis, with a particular focus on new technologies: Imaging and drugs. She lectures widely in the UK and internationally on amyloidosis and organises many multi-professional educational events. She is on the board of trustees of SCMR and chair of the Education Committee for the society. She advises industry at all stages in the lifecycle of innovative products that can help improve the life-expectancy and quality of life of patients with amyloidosis. She is the recipient of numerous awards, including the Michael Davies Early Career Award in 2021 and the BHF Fellow of the year award in 2022. She has co-authored 217 peer reviewed publications with >13700 citations (h-index 64). 


Read full bio